Clinical trial · Interventional
Intervention Study of Depression in Breast Cancer Patients
Early Identification and Early Warning of Psychological Problems in Breast Cancer Patients, and Intervention Study Using Cognitive Behavioral Therapy on Depression in Breast Cancer Patients
NCT01256008CI-TRIAL-00017756completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the efficacy of cognitive-behavioral therapy on depression and anxiety in breast cancer patients.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anxiety | — | UNRESOLVED | — |
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Depression | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CBT | Behavioral | — | UNRESOLVED |
| Clinical Management | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- PLACEBO_COMPARATOR
- label
- stage 1 Clinical Management
- description
- The group will receive clinical management treatment only each session.
- interventionNames
- Behavioral: Clinical Management
- type
- EXPERIMENTAL
- label
- stage1 CBT
- description
- The experimental group will receive CBT
- interventionNames
- Behavioral: CBT
- type
- NO_INTERVENTION
- label
- stage1 Control group
- description
- Participants with breast cancer in the control group received standard medical care, but don't receive any other interventions.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Age: 20-65 years; * Pathologically diagnosed breast cancer patients, with the diagnosis from at least 2 comprehensive clinical attending physicians, in line with clinical diagnosis of breast cancer; * A week after breast cancer surgery; * With complaints and symptoms of depression or anxiety * HAMD-17 ≥ 8 points or / and HAMA ≥ 8 points; * Have some reading comprehension skills (could complete the self-rating scale independently or with others' help); * Informed consent Exclusion Criteria: * Previous diagnosis of mental disorder or Bipolar Disorder; alcohol and drug abusing history; * Use antidepressants, antipsychotics or accept any form of psychological treatment, or participation in other clinical trials in the last month * Patients with cardiovascular disease, liver and kidney dysfunction and other serious diseases; * Hearing, visual or understanding impairment; * Severe depression, suicidal tendencies; * Can not or will not comply with clinical treatment programs based on the physicians' judgment Exit criteria: * Persons with poor compliance during the trial period; * Persons whose depression increased during the trial period, has serious suicidal tendencies and requires urgent intervention; * Persons who are believed have other circumstances and should be suspended by Physicians
References
Publications (0)
Data not yet available
No reference posted for this study.